This inventor holds 1 USPTO granted patent. Top assignee: Nissho Corporation. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kenji Sugimoto: Innovator in Blood Dialysis Technology
Introduction
Kenji Sugimoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical technology, particularly in blood dialysis. His innovative approach has led to the development of a unique method for washing hollow fiber membranes, which are crucial in dialysis procedures.
Latest Patents
Kenji Sugimoto holds a patent for a "Method for washing hollow fiber membrane." This method involves washing the inner wall of the hollow fiber with a clearing solvent that primarily consists of a specific aliphatic hydrocarbon. This hydrocarbon has a boiling point of 110-240 degrees Celsius and a flash point of not less than 21 degrees Celsius. The invention allows for the selective removal of lipophilic liquid from the core of the hollow fiber without affecting the glycerol in the pores. Additionally, this method addresses concerns regarding flammability and environmental pollution.
Career Highlights
Sugimoto is associated with Nissho Corporation, where he has been able to apply his expertise in developing innovative solutions for medical applications. His work has not only advanced the technology used in blood dialysis but has also contributed to improving patient safety and treatment efficacy.
Collaborations
Kenji Sugimoto has collaborated with notable colleagues, including Takeshi Nizuka and Takashi Uemura. Their combined efforts have fostered a productive environment for innovation and development within their field.
Conclusion
Kenji Sugimoto's contributions to blood dialysis technology exemplify the impact of innovation in healthcare. His patented method for washing hollow fiber membranes represents a significant advancement in medical technology, enhancing both safety and effectiveness in treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile